Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
930 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC
Conditions: Lung Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Lung Diseases;   Respiratory Tract Disease;   Neoplasms by Site;   Neoplasm, Bronchial;   Carcinoma, Bronchogenic
Interventions: Biological: SHR-1210;   Drug: Carboplatin;   Drug: Pemetrexed
6 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
7 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
8 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
9 Recruiting Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Patient Reported Outcomes
10 Recruiting Phase 1 Study of LOXO-292 in Patients With Advanced Solid Tumors, RET-Fusion Lung Cancer and Medullary Thyroid Cancer
Conditions: Non-Small Cell Lung Cancer;   Medullary Thyroid Cancer;   Colon Cancer;   Solid Tumor
Intervention: Drug: LOXO-292
11 Not yet recruiting Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients
Condition: Metastatic Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Avelumab;   Radiation: Stereotactic ablative radiotherapy (SAR)
12 Not yet recruiting This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
Conditions: Neoplasms;   Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BI 754111;   Drug: BI 754091
13 Not yet recruiting A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Alectinib
14 Recruiting Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation
Condition: Lung, Carcinoma
Interventions: Drug: Icotinib,Pemetrexed,Carboplatin;   Drug: Icotinib
15 Not yet recruiting PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Conditions: Solid Tumor, Adult;   Breast Cancer;   Non Small Cell Lung Cancer;   Prostate Cancer;   Ovarian Cancer;   Endometrial Cancer;   Head and Neck Cancer;   Cholangiocarcinoma
Intervention: Drug: CX-2009
16 Not yet recruiting Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab (MEDI 4736);   Radiation: Radiotherapy
17 Not yet recruiting Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M (BOOSTER)
Condition: Non Small Cell Lung Cancer Metastatic
Interventions: Drug: Osimertinib;   Drug: Bevacizumab
18 Recruiting MAGE-A4ᶜ¹º³²T for Multi-Tumor
Conditions: Bladder Cancer;   Melanoma;   Head and Neck Cancer;   Ovarian Cancer;   Non-Small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer
Intervention: Genetic: Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
19 Not yet recruiting To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
Conditions: NSCLC Stage IV;   NSCLC, Stage III
Interventions: Dietary Supplement: Oligo Fucoidan;   Dietary Supplement: Placebo
20 Recruiting The Efficacy and Safety of Apatinib Monotherapy in Maintenance Treatment of Extensive-stage Small-cell Lung Cancer
Condition: Apatinib in Maintenance Treatment
Intervention: Drug: Apatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.